Hypertrophic obstructive cardiomyopathy in an infant of a diabetic mother: support by extracorporeal membrane oxygenation and treatment with beta-adrenergic blockade and increased intravenous fluid administration.
In infants with hypertrophic obstructive cardiomyopathy (HOCM) on extracorporeal membrane oxygenation (ECMO), conventional treatment with inotropes, fluid restriction, and diuretics may be detrimental. This case reports an infant of a diabetic mother with HOCM on ECMO illustrating beneficial effects of beta adrenergic blockade and increased fluid administration.
Robinson
B
B
Section of Pediatric Cardiology, MCP-Hahnemann School of Medicine and St. Christopher's Hospital for Children, Philadelphia, Pennsylvania 19134, USA.
Eshaghpour
E
E
Ewing
S
S
Baumgart
S
S
D000319:Adrenergic beta-Antagonists / Q000627:therapeutic use*; D002312:Cardiomyopathy, Hypertrophic / Q000628:therapy*; D015199:Extracorporeal Membrane Oxygenation; D005260:Female; D005440:Fluid Therapy; D006801:Humans; D007231:Infant, Newborn; D011247:Pregnancy; D011254:Pregnancy in Diabetics / Q000150:complications*; D011412:Propanolamines / Q000627:therapeutic use*
D000319:Adrenergic beta-Antagonists; D011412:Propanolamines; C036604:esmolol